Cargando…

Management of hip fracture in COVID-19 infected patients

Given that the global population of elderly individuals is expanding and the difficulty of recovery, hip fractures will be a huge challenge and a critical health issue for all of humanity. Although people have spent more time at home during the coronavirus disease 2019 (COVID-19) pandemic, hip fract...

Descripción completa

Detalles Bibliográficos
Autores principales: Qin, Hao-Cheng, He, Zhong, Luo, Zhi-Wen, Zhu, Yu-Lian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9244961/
https://www.ncbi.nlm.nih.gov/pubmed/35949705
http://dx.doi.org/10.5312/wjo.v13.i6.544
_version_ 1784738643790790656
author Qin, Hao-Cheng
He, Zhong
Luo, Zhi-Wen
Zhu, Yu-Lian
author_facet Qin, Hao-Cheng
He, Zhong
Luo, Zhi-Wen
Zhu, Yu-Lian
author_sort Qin, Hao-Cheng
collection PubMed
description Given that the global population of elderly individuals is expanding and the difficulty of recovery, hip fractures will be a huge challenge and a critical health issue for all of humanity. Although people have spent more time at home during the coronavirus disease 2019 (COVID-19) pandemic, hip fractures show no sign of abating. Extensive studies have shown that patients with hip fracture and COVID-19 have a multifold increase in mortality compared to those uninfected and a more complex clinical condition. At present, no detailed research has systematically analyzed the relationship between these two conditions and proposed a comprehensive solution. This article aims to systematically review the impact of COVID-19 on hip fracture and provide practical suggestions. We found that hip fracture patients with COVID-19 have higher mortality rates and more complicated clinical outcomes. Indirectly, COVID-19 prevents hip fracture patients from receiving regular medical treatment. With regard to the problems we encounter, we provide clinical recommendations based on existing research evidence and a clinical flowchart for the management of hip fracture patients who are COVID-19 positive. Our study will help clinicians adequately prepare in advance when dealing with such patients and optimize treatment decisions.
format Online
Article
Text
id pubmed-9244961
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Baishideng Publishing Group Inc
record_format MEDLINE/PubMed
spelling pubmed-92449612022-08-09 Management of hip fracture in COVID-19 infected patients Qin, Hao-Cheng He, Zhong Luo, Zhi-Wen Zhu, Yu-Lian World J Orthop Minireviews Given that the global population of elderly individuals is expanding and the difficulty of recovery, hip fractures will be a huge challenge and a critical health issue for all of humanity. Although people have spent more time at home during the coronavirus disease 2019 (COVID-19) pandemic, hip fractures show no sign of abating. Extensive studies have shown that patients with hip fracture and COVID-19 have a multifold increase in mortality compared to those uninfected and a more complex clinical condition. At present, no detailed research has systematically analyzed the relationship between these two conditions and proposed a comprehensive solution. This article aims to systematically review the impact of COVID-19 on hip fracture and provide practical suggestions. We found that hip fracture patients with COVID-19 have higher mortality rates and more complicated clinical outcomes. Indirectly, COVID-19 prevents hip fracture patients from receiving regular medical treatment. With regard to the problems we encounter, we provide clinical recommendations based on existing research evidence and a clinical flowchart for the management of hip fracture patients who are COVID-19 positive. Our study will help clinicians adequately prepare in advance when dealing with such patients and optimize treatment decisions. Baishideng Publishing Group Inc 2022-06-18 /pmc/articles/PMC9244961/ /pubmed/35949705 http://dx.doi.org/10.5312/wjo.v13.i6.544 Text en ©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. https://creativecommons.org/licenses/by-nc/4.0/This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
spellingShingle Minireviews
Qin, Hao-Cheng
He, Zhong
Luo, Zhi-Wen
Zhu, Yu-Lian
Management of hip fracture in COVID-19 infected patients
title Management of hip fracture in COVID-19 infected patients
title_full Management of hip fracture in COVID-19 infected patients
title_fullStr Management of hip fracture in COVID-19 infected patients
title_full_unstemmed Management of hip fracture in COVID-19 infected patients
title_short Management of hip fracture in COVID-19 infected patients
title_sort management of hip fracture in covid-19 infected patients
topic Minireviews
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9244961/
https://www.ncbi.nlm.nih.gov/pubmed/35949705
http://dx.doi.org/10.5312/wjo.v13.i6.544
work_keys_str_mv AT qinhaocheng managementofhipfractureincovid19infectedpatients
AT hezhong managementofhipfractureincovid19infectedpatients
AT luozhiwen managementofhipfractureincovid19infectedpatients
AT zhuyulian managementofhipfractureincovid19infectedpatients